{"id":551993,"date":"2026-06-02T07:15:13","date_gmt":"2026-06-02T07:15:13","guid":{"rendered":"https:\/\/www.capgemini.com\/co-es\/?post_type=research-and-insight&#038;p=551993"},"modified":"2026-06-02T07:15:24","modified_gmt":"2026-06-02T07:15:24","slug":"reinventando-el-modelo-insostenible-de-id-farmaceutica","status":"publish","type":"research-and-insight","link":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","title":{"rendered":"Reinventando el modelo insostenible de I+D farmac\u00e9utica"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-reusable header heroReusable  \"><div class=\"header-bgs\"><picture><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=2880&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 1500px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=1440&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 992px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=1024&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=1024&amp;quality=70 2x\" media=\"(min-width: 768px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=768&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg?w=768&amp;quality=70 2x\" media=\"(min-width: 0)\"\/><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/LS-Pharma-RD-Web-banner.jpg\" class=\"header-img header-img-d\" alt=\"\" style=\"object-fit:cover;object-position:53% 93%\" loading=\"eager\"\/><\/picture><\/div><div class=\"heroPictureCardHeaderShape\"><\/div><div class=\"container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"box\"><div class=\"boxTagWrapper\"><div class=\"tagInfo\"><div><span class=\"box-tag\">Health<\/span><\/div><\/div><div class=\"brandInfo\"><div class=\"brandLogo\"><img decoding=\"async\" loading=\"lazy\" src=\"\/wp-content\/themes\/capgemini2025\/assets\/images\/capgemini-invent-white.svg\" alt=\"capgemini-invent\" class=\"dark\"\/><img decoding=\"async\" loading=\"lazy\" src=\"\/wp-content\/themes\/capgemini2025\/assets\/images\/capgemini-invent.svg\" alt=\"capgemini-invent\" class=\"light\"\/><\/div><\/div><\/div><div class=\"box-title\"><h1 data-maxlength=\"34\">Reinventando el modelo insostenible de I+D farmac\u00e9utica<\/h1><\/div><div class=\"inner-row-insight download-btn\"><\/div><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-2\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/co-es\/?post_type=research-and-insight&amp;p=551993\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/co-es\/?post_type=research-and-insight&amp;p=551993\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-8\"><p class=\"intro-para-content-withoutTitle\">Los avances en biotecnolog\u00eda est\u00e1n impulsando algunas de las oportunidades m\u00e1s prometedoras en todos los \u00e1mbitos. Existen dos razones sencillas para ello. En primer lugar, los acontecimientos recientes han demostrado cu\u00e1n vital y demandada resulta la innovaci\u00f3n en este \u00e1mbito. En segundo lugar, la financiaci\u00f3n de capital riesgo y el gasto en este sector han crecido un 45 % en tan solo ocho a\u00f1os. Sin embargo, a pesar de esto, muchos tratamientos nuevos y prometedores podr\u00edan no llegar nunca al mercado. \u00bfLa raz\u00f3n? El actual modelo de I+D de muchas compa\u00f1\u00edas farmac\u00e9uticas es insostenible.<br><br>En nuestra reciente publicaci\u00f3n de Capgemini, analizamos el panorama actual de la industria farmac\u00e9utica, destacando los desaf\u00edos que las empresas deben superar no ma\u00f1ana, sino hoy mismo. Es imperativo abordar cuestiones como el aumento de los costos, los largos ciclos de tiempo, la productividad, los procesos de aprobaci\u00f3n y la gesti\u00f3n de los pagadores en I+D. Nuestro enfoque trilateral para reinventar el modelo de I+D permite a las organizaciones lograr precisamente eso.<\/p><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"grid-container\"><div><div class=\"article-text article-quote-text\">\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile\" style=\"grid-template-columns:auto 46%\"><div class=\"wp-block-media-text__content\">\n<h3 class=\"wp-block-heading\" id=\"h-liderazgo-de-pensamiento\">Liderazgo de pensamiento<\/h3>\n\n\n\n<p>En nuestra reciente publicaci\u00f3n de Capgemini, analizamos el estado actual de la industria farmac\u00e9utica, destacando los desaf\u00edos que las empresas deben superar no ma\u00f1ana, sino hoy.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/PoV_Pharmaceutical-RD.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Descargar el informe<\/a><\/div>\n<\/div>\n<\/div><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2022\/12\/Cover-image.png?w=960\" alt=\"\" class=\"wp-image-835353 size-full\"\/><\/figure><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>En nuestra reciente publicaci\u00f3n de Capgemini, analizamos el estado actual de la industria farmac\u00e9utica, destacando los desaf\u00edos que las empresas deben superar no ma\u00f1ana, sino hoy.<\/p>\n","protected":false},"author":290,"featured_media":551994,"template":"","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"810e321c-f015-48ea-b8a5-338b4d938e59\",\"blogId\":\"1\",\"domain\":\"www.capgemini.com\",\"sitePath\":\"\/\",\"postLink\":\"https:\/\/www.capgemini.com\/insights\/research-library\/reinventing-the-unsustainable-pharmaceutical-rd-model\/\",\"postId\":835349,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false,\"isEnabled\":true}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"footnotes":"","related_resource_url":"","related_resource_id":0,"related_resource_size":"","related_resource_type":"","cg_author":0,"_yoast_wpseo_primary_theme":252,"primary_term":"Health","featured_focal_points":""},"tags":[],"research-and-insight-type":[78],"theme":[252],"brand":[79],"service":[],"industry":[],"partners":[],"content-group":[],"class_list":["post-551993","research-and-insight","type-research-and-insight","status-publish","has-post-thumbnail","hentry","research-and-insight-type-point-of-view","theme-healthcare","brand-capgemini-invent"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Reinventando la I+D Farmac\u00e9utica | Capgemini<\/title>\n<meta name=\"description\" content=\"Descubre c\u00f3mo reinventar la I+D farmac\u00e9utica para mejorar eficiencia, innovaci\u00f3n y sostenibilidad en el sector salud.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/mx-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reinventando el modelo insostenible de I+D farmac\u00e9utica\" \/>\n<meta property=\"og:description\" content=\"Descubre c\u00f3mo reinventar la I+D farmac\u00e9utica para mejorar eficiencia, innovaci\u00f3n y sostenibilidad en el sector salud.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini Colombia\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-02T07:15:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/\",\"name\":\"Reinventando la I+D Farmac\u00e9utica | Capgemini\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg\",\"datePublished\":\"2026-06-02T07:15:13+00:00\",\"dateModified\":\"2026-06-02T07:15:24+00:00\",\"description\":\"Descubre c\u00f3mo reinventar la I+D farmac\u00e9utica para mejorar eficiencia, innovaci\u00f3n y sostenibilidad en el sector salud.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"es-MX\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg\",\"width\":2880,\"height\":1800,\"caption\":\"pharma R&D\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/co-es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reinventando el modelo insostenible de I+D farmac\u00e9utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/\",\"name\":\"Capgemini Colombia\",\"description\":\"Capgemini\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es-MX\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Reinventando la I+D Farmac\u00e9utica | Capgemini","description":"Descubre c\u00f3mo reinventar la I+D farmac\u00e9utica para mejorar eficiencia, innovaci\u00f3n y sostenibilidad en el sector salud.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/mx-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","og_locale":"es_MX","og_type":"article","og_title":"Reinventando el modelo insostenible de I+D farmac\u00e9utica","og_description":"Descubre c\u00f3mo reinventar la I+D farmac\u00e9utica para mejorar eficiencia, innovaci\u00f3n y sostenibilidad en el sector salud.","og_url":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","og_site_name":"Capgemini Colombia","article_modified_time":"2026-06-02T07:15:24+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","url":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","name":"Reinventando la I+D Farmac\u00e9utica | Capgemini","isPartOf":{"@id":"https:\/\/www.capgemini.com\/co-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg","datePublished":"2026-06-02T07:15:13+00:00","dateModified":"2026-06-02T07:15:24+00:00","description":"Descubre c\u00f3mo reinventar la I+D farmac\u00e9utica para mejorar eficiencia, innovaci\u00f3n y sostenibilidad en el sector salud.","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#breadcrumb"},"inLanguage":"es-MX","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#primaryimage","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg","contentUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg","width":2880,"height":1800,"caption":"pharma R&D"},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/co-es\/"},{"@type":"ListItem","position":2,"name":"Reinventando el modelo insostenible de I+D farmac\u00e9utica"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/co-es\/#website","url":"https:\/\/www.capgemini.com\/co-es\/","name":"Capgemini Colombia","description":"Capgemini","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es-MX"}]}},"theme_term_info":[{"id":252,"name":"Health"}],"industry_term_info":[],"services_term_info":[],"partners_term_info":[],"brand_term_info":[{"id":79,"name":"Capgemini Invent","slug":"capgemini-invent"}],"brand_term":[{"id":79,"slug":"capgemini-invent"}],"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Reinventando el modelo insostenible de I+D farmac\u00e9utica","url":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini Colombia","logo":""},"keywords":[],"dateCreated":"2026-06-02T07:15:13Z","datePublished":"2026-06-02T07:15:13Z","dateModified":"2026-06-02T07:15:24Z"},"rendered":"<meta name=\"parsely-title\" content=\"Reinventando el modelo insostenible de I+D farmac\u00e9utica\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/reinventando-el-modelo-insostenible-de-id-farmaceutica\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2026-06-02T07:15:13Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg","featured_image_alt":"pharma R&D","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini Colombia","distributor_original_site_url":"https:\/\/www.capgemini.com\/co-es","push-errors":false,"tag_names":[],"featured_image_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/LS-Pharma-RD-Web-banner.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight\/551993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight"}],"about":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/types\/research-and-insight"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/users\/290"}],"version-history":[{"count":1,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight\/551993\/revisions"}],"predecessor-version":[{"id":551995,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight\/551993\/revisions\/551995"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media\/551994"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media?parent=551993"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/tags?post=551993"},{"taxonomy":"research-and-insight-type","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight-type?post=551993"},{"taxonomy":"theme","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/theme?post=551993"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/brand?post=551993"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/service?post=551993"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/industry?post=551993"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/partners?post=551993"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/content-group?post=551993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}